- Home
- ICCC vs JMM Comparison
ICCC vs JMM Comparison
Compare ICCC & JMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- JMM
- Stock Information
- Founded
- ICCC 1982
- JMM 1988
- Country
- ICCC United States
- JMM United States
- Employees
- ICCC N/A
- JMM N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- JMM Trusts Except Educational Religious and Charitable
- Sector
- ICCC Health Care
- JMM Finance
- Exchange
- ICCC Nasdaq
- JMM Nasdaq
- Market Cap
- ICCC 55.5M
- JMM 59.8M
- IPO Year
- ICCC 1987
- JMM N/A
- Fundamental
- Price
- ICCC $6.16
- JMM $6.22
- Analyst Decision
- ICCC
- JMM
- Analyst Count
- ICCC 0
- JMM 0
- Target Price
- ICCC N/A
- JMM N/A
- AVG Volume (30 Days)
- ICCC 19.4K
- JMM 16.1K
- Earning Date
- ICCC 11-13-2025
- JMM 01-01-0001
- Dividend Yield
- ICCC N/A
- JMM 5.44%
- EPS Growth
- ICCC N/A
- JMM N/A
- EPS
- ICCC 0.20
- JMM N/A
- Revenue
- ICCC $28,274,756.00
- JMM N/A
- Revenue This Year
- ICCC N/A
- JMM N/A
- Revenue Next Year
- ICCC N/A
- JMM N/A
- P/E Ratio
- ICCC $31.10
- JMM N/A
- Revenue Growth
- ICCC 21.75
- JMM N/A
- 52 Week Low
- ICCC $3.38
- JMM $5.29
- 52 Week High
- ICCC $7.60
- JMM $6.10
- Technical
- Relative Strength Index (RSI)
- ICCC 46.17
- JMM 41.35
- Support Level
- ICCC $6.06
- JMM $6.17
- Resistance Level
- ICCC $6.75
- JMM $6.26
- Average True Range (ATR)
- ICCC 0.36
- JMM 0.07
- MACD
- ICCC -0.04
- JMM -0.01
- Stochastic Oscillator
- ICCC 15.31
- JMM 9.32
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities including, but not limited to residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.